The tweet was deleted by the author.
But we saved everything 🙂.
CME Group reports that dividend futures and options surged in the first quarter.
Market participants sought a capital-efficient solution for managing dividend risk. Details are available via the provided link.
View post on X Loading...
CME Group is trading at $295.30, which is well below the MA-20 ($304.35) and MA-50 ($305.59), but above the MA-200 ($280.57). This setup signals short- and medium-term bearish pressure, while the long-term trend remains supported by the 200-day average. The Ichimoku Kijun on D1 sits at $307.39, serving as immediate resistance. Near-term support is defined by the MA-200 ($280.57), with key support at MA-100 ($290.16). Immediate resistance is clustered around the MA-20 ($304.35) and Ichimoku Kijun ($307.39), while key resistance stands at MA-50 ($305.59).
MACD and ADX on D1 both indicate weakening momentum, with MACD issuing a strong sell signal and ADX at a low value, pointing to a lack of clear trend strength. RSI, CCI, and Stoch RSI are all skewed toward the bearish side, with CCI and BBP also signaling oversold levels and suggesting sellers are currently in control of intraday momentum. Although the Awesome Oscillator is neutral, it does not contradict this overall bearish tone. CME has fallen $9.81 (3.22%) over the past week, trading down from last week's close at $305.11, near the very bottom of the weekly range. Weekly volatility stands at 5.05%, and the weekly tone is one of a steady decline from earlier highs. In today’s session, the price has dropped 1.21%, reinforcing the current bearish momentum.
Looking ahead, the expected price range for the next week is $281.00 to $305.00, anchored around the current price and normalized for typical volatility. This keeps CME safely above its 52-week low of $251.90 and below its 52-week high of $329.16. With "Buy" or "Strong Buy" signals from all major W1 indicators (MA-50, RSI, MACD, ADX), the probability of a price increase is very high (more than 80%), while a decline is much less likely. In the baseline scenario, CME trades sideways within this range. A bullish scenario would require a decisive move above resistance levels near $305.00–$307.39, regaining lost ground. In a bearish breakdown, failure to hold above $290.00 could see a push toward the long-term support at $280.57.
Previously it was reported that CME Group exhibited persistent but stabilizing selling pressure, with analysts expecting consolidation and a potential upside bias despite recent short-term volatility. In light of the latest developments, traders should closely monitor CME's response to upcoming earnings as a key directional catalyst for near-term price action.